Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. Operating Income 2017–2020
Cogent Biosciences, Inc. annual/quarterly operating income history and growth rate from 2017 to 2020. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cogent Biosciences, Inc. operating income for the quarter ending September 30, 2020 was -57.2 M, a 375.23% increase year-over-year.
- Cogent Biosciences, Inc. operating income for the twelve months ending September 30, 2020 was -82.8 M, a 95.25% increase year-over-year.
- Cogent Biosciences, Inc. annual operating income for 2020 was -82.2 M, a 155.45% increase from 2019.
- Cogent Biosciences, Inc. annual operating income for 2019 was -32.2 M, a 10.63% decrease from 2018.
- Cogent Biosciences, Inc. annual operating income for 2018 was -36.0 M, a 37.68% increase from 2017.
- Cogent Biosciences, Inc. annual operating income for 2017 was -26.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cogent Biosciences, Inc. Operating Income — FAQ
Cogent Biosciences, Inc. (COGT) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Cogent Biosciences, Inc.'s operating income?
Cogent Biosciences, Inc. (COGT) reported operating income of -$82M for fiscal 2020.
Where can I see COGT's operating income history?
The chart and table above show Cogent Biosciences, Inc.'s operating income by year and by quarter, including the growth rate.